ClearanceBrief
Panels › Microbiology › Product code LON · Class 2

System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

Regulation 866.1645

4510(k)s in 12 months (291 all time)
6recalls in 12 months (240 all time)
161recalls that name a 510(k)
Get daily alerts for LONSample briefCSV

Top companies in LON

Decided510(k)Device and applicantCode
Oct 1, 2026K260283VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL)
bioMerieux, Inc.
LON
Sep 28, 2026K260619VITEK 2 AST-Streptococcus Cefepime (<=0.06 – >=4 µg/mL)
Biomérieux, Inc.
LON
Apr 15, 2026K260282VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance
bioMerieux, Inc.
LON
Mar 26, 2026K260281VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
BIOMERIEUX
LON
Aug 21, 2025K251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)
bioMerieux, Inc.
LON
Aug 8, 2025K251713BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)
Becton, Dickinson and Company
LON
May 19, 2025K250447BD Phoenix™ Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)
Becton, Dickinson and Company
LON
Mar 14, 2025K234012VITEK COMPACT PRO
bioMerieux, Inc.
LON
Mar 6, 2025K250344BD Phoenix™ Automated Microbiology System
Becton, Dickinson and Company
LON
Mar 15, 2024K233986BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL)
Becton, Dickinson and Company
LON
Mar 11, 2024K234000VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL)
bioMerieux, Inc.
LON
Dec 27, 2023K232756Colibrí
Copan Wasp Srl, IT
LON
Oct 23, 2023K232201VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK
bioMerieux, Inc.
LON
Jul 5, 2023K230864VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-G
bioMerieux, Inc.
LON
Jun 26, 2023K222378VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL)
bioMerieux, Inc.
LON
Apr 19, 2023K211748Selux AST System; Model AST Gen 1.0
Selux Diagnostics, Inc.
LON
Mar 9, 2023K222430VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN
Biomerieux Sa, Inc.
LON
Feb 16, 2023K223478VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-
bioMerieux, Inc.
LON
Feb 9, 2023K222073VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL)
bioMerieux, Inc.
LON
Feb 3, 2023K223481VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL)
bioMerieux, Inc.
LON
Jan 27, 2023K220803VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-
bioMerieux, Inc.
LON
Jan 18, 2023K211759Selux AST System; Model AST Gen 1.0
Selux Diagnostics, Inc.
LON
Oct 13, 2022K220805VITEK 2 AST-Gram Positive Cefoxitin Screen
bioMerieux, Inc.
LON
Oct 5, 2022K220546Colibrí System
Copan Wasp Srl, IT
LON
Aug 8, 2022K212243VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL)
bioMerieux, Inc.
LON
Jul 12, 2022K213899VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-
bioMerieux, Inc.
LON
Jun 3, 2022K213931VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL)
bioMerieux, Inc.
LON
Apr 14, 2022K214023VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL)
bioMerieux, Inc.
LON
Feb 25, 2022K213241VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconaz
bioMerieux, Inc.
LON
Feb 4, 2022K212849VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL)
Biomérieux, Inc.
LON
Oct 28, 2021K210287VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)
bioMerieux, Inc.
LON
Sep 14, 2021K202396VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL)
bioMerieux, Inc.
LON
Aug 30, 2021K211630VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL)
bioMerieux, Inc.
LON
Jul 9, 2021K201675VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL)
bioMerieux, Inc.
LON
Jun 14, 2021K211136VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)
bioMerieux, Inc.
LON
Sep 28, 2020K193299VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL)
bioMerieux, Inc.
LON
Aug 30, 2020K201405LabPro Data Management System
Beckman Coulter, Inc.
LON
Apr 28, 2020K200590VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL)
bioMerieux, Inc.
LON
Mar 13, 2020K193572VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL)
bioMerieux, Inc.
LON
Feb 14, 2020K193567VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL)
bioMerieux, Inc.
LON
Oct 31, 2019K192110Vitek Densichek
bioMerieux, Inc.
LON
Aug 5, 2019K191766VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL)
bioMerieux, Inc.
LON
Jul 1, 2019K190905BD Phoenix Automated Microbiology System – GN Ceftaroline (0.0156-4 µg/mL)
Becton, Dickinson and Company
LON
Jun 6, 2019K190616VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL)
bioMerieux, Inc.
LON
Mar 12, 2019K183524VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL)
bioMerieux, Inc.
LON
Mar 7, 2019K183551VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL)
bioMerieux, Inc.
LON
Feb 26, 2019K183360VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL)
bioMerieux, Inc.
LON
Feb 20, 2019K183415VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL)
bioMerieux, Inc.
LON
Dec 10, 2018K181766VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance
bioMerieux, Inc.
LON
Sep 21, 2018K181665BD Phoenix Automated Microbiology System - BD Phoenix CPO detect - GN
Becton, Dickinson and Company
LON

Free CSV: newest 100 rows. Paid plans export up to 1,000 or 10,000 rows.